Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 3
1979 4
1980 6
1981 7
1982 11
1983 8
1984 7
1985 9
1986 9
1987 10
1988 19
1989 15
1990 14
1991 13
1992 17
1993 17
1994 16
1995 13
1996 14
1997 19
1998 16
1999 16
2000 15
2001 9
2002 12
2003 13
2004 9
2005 14
2006 12
2007 13
2008 7
2009 17
2010 16
2011 12
2012 14
2013 18
2014 18
2015 15
2016 24
2017 24
2018 17
2019 11
2020 17
2021 18
2022 14
2023 5
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

561 results

Results by year

Filters applied: . Clear all
Page 1
High-dose vitamin C enhances cancer immunotherapy.
Magrì A, Germano G, Lorenzato A, Lamba S, Chilà R, Montone M, Amodio V, Ceruti T, Sassi F, Arena S, Abrignani S, D'Incalci M, Zucchetti M, Di Nicolantonio F, Bardelli A. Magrì A, et al. Among authors: d incalci m. Sci Transl Med. 2020 Feb 26;12(532):eaay8707. doi: 10.1126/scitranslmed.aay8707. Sci Transl Med. 2020. PMID: 32102933 Free article.
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth.
Germano G, Lamba S, Rospo G, Barault L, Magrì A, Maione F, Russo M, Crisafulli G, Bartolini A, Lerda G, Siravegna G, Mussolin B, Frapolli R, Montone M, Morano F, de Braud F, Amirouchene-Angelozzi N, Marsoni S, D'Incalci M, Orlandi A, Giraudo E, Sartore-Bianchi A, Siena S, Pietrantonio F, Di Nicolantonio F, Bardelli A. Germano G, et al. Among authors: d incalci m. Nature. 2017 Dec 7;552(7683):116-120. doi: 10.1038/nature24673. Epub 2017 Nov 29. Nature. 2017. PMID: 29186113 Free article.
Translocation-related sarcomas.
Mertens F, Antonescu CR, Hohenberger P, Ladanyi M, Modena P, D'Incalci M, Casali PG, Aglietta M, Alvegård T. Mertens F, et al. Among authors: d incalci m. Semin Oncol. 2009 Aug;36(4):312-23. doi: 10.1053/j.seminoncol.2009.06.004. Semin Oncol. 2009. PMID: 19664492 Review.
Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer.
Paracchini L, Mannarino L, Romualdi C, Zadro R, Beltrame L, Fuso Nerini I, Zola P, Laudani ME, Pagano E, Giordano L, Fruscio R, Landoni F, Franceschi S, Dalessandro ML, Canzonieri V, Bocciolone L, Lorusso D, Bosetti C, Raspagliesi F, Garassino IMG; TOWARDS group; D'Incalci M, Marchini S. Paracchini L, et al. Among authors: d incalci m. Sci Transl Med. 2023 Dec 6;15(725):eadi2556. doi: 10.1126/scitranslmed.adi2556. Epub 2023 Dec 6. Sci Transl Med. 2023. PMID: 38055801 Free article.
DNA Damage Response and Immune Defense.
Nastasi C, Mannarino L, D'Incalci M. Nastasi C, et al. Among authors: d incalci m. Int J Mol Sci. 2020 Oct 12;21(20):7504. doi: 10.3390/ijms21207504. Int J Mol Sci. 2020. PMID: 33053746 Free PMC article. Review.
Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma.
Digifico E, Erreni M, Mannarino L, Marchini S, Ummarino A, Anfray C, Bertola L, Recordati C, Pistillo D, Roncalli M, Bossi P, Zucali PA, D'Incalci M, Belgiovine C, Allavena P. Digifico E, et al. Among authors: d incalci m. Front Immunol. 2023 Jun 16;14:1116430. doi: 10.3389/fimmu.2023.1116430. eCollection 2023. Front Immunol. 2023. PMID: 37398648 Free PMC article.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Among authors: d incalci m. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Clinical pharmacokinetics of altretamine.
Damia G, D'Incalci M. Damia G, et al. Among authors: d incalci m. Clin Pharmacokinet. 1995 Jun;28(6):439-48. doi: 10.2165/00003088-199528060-00002. Clin Pharmacokinet. 1995. PMID: 7656502 Review.
DNA-topoisomerase inhibitors.
D'Incalci M. D'Incalci M. Curr Opin Oncol. 1993 Nov;5(6):1023-8. Curr Opin Oncol. 1993. PMID: 8305535 Review.
Some hope from marine natural products.
D'Incalci M. D'Incalci M. Ann Oncol. 1998 Sep;9(9):937-8. doi: 10.1023/A:1008434911352. Ann Oncol. 1998. PMID: 9818065 Free article. No abstract available.
561 results